Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

The9 (NCTY) Common Equity (2016 - 2024)

Historic Common Equity for The9 (NCTY) over the last 17 years, with Q2 2025 value amounting to $54.6 million.

  • The9's Common Equity rose 1850.13% to $54.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $54.6 million, marking a year-over-year increase of 1850.13%. This contributed to the annual value of $47.1 million for FY2024, which is 7400.98% down from last year.
  • According to the latest figures from Q2 2025, The9's Common Equity is $54.6 million, which was up 1850.13% from $47.1 million recorded in Q4 2024.
  • In the past 5 years, The9's Common Equity registered a high of $119.4 million during Q4 2021, and its lowest value of -$26.4 million during Q2 2023.
  • In the last 5 years, The9's Common Equity had a median value of $45.9 million in 2022 and averaged $39.9 million.
  • The largest annual percentage gain for The9's Common Equity in the last 5 years was 63990.67% (2023), contrasted with its biggest fall of 15782.63% (2023).
  • The9's Common Equity (Quarter) stood at $119.4 million in 2021, then plummeted by 96.76% to $3.9 million in 2022, then surged by 639.91% to $28.6 million in 2023, then soared by 64.56% to $47.1 million in 2024, then rose by 15.88% to $54.6 million in 2025.
  • Its Common Equity stands at $54.6 million for Q2 2025, versus $47.1 million for Q4 2024 and $46.1 million for Q2 2024.